Headquarters
43 FOUNDRY AVE STE 120, WALTHAM, MA 02453-8313, US
WALTHAM, MA, US
From the company
Affinia Therapeutics is a gene therapy company developing adeno-associated virus (AAV) gene therapies for rare and prevalent diseases, starting with diseases of the heart and nervous system. Its proprietary ART (Affinia Rationally-designed Therapies) platform uses AI and structural modeling to rationally design novel AAV capsids and therapeutic payloads. Its first program, AFTX-201, targets BAG3-associated dilated cardiomyopathy (DCM).
43 FOUNDRY AVE STE 120, WALTHAM, MA 02453-8313, US
Quantities, certifications, and timing.